Covid-19
Showing NaN - NaN of 62
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Cardiac Arrest, COVID-19, Coronavirus Trial in Canada, United States (Aerosol box)
Not yet recruiting
- Cardiac Arrest
- +2 more
- Aerosol box
-
Los Angeles, California
- +3 more
May 23, 2023
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
SARS CoV 2 Infection, COVID-19 Trial in Los Angeles (Bemnifosbuvir (BEM), Placebo)
Recruiting
- SARS CoV 2 Infection
- COVID-19
- Bemnifosbuvir (BEM)
- Placebo
-
Los Angeles, CaliforniaAtea Study Site
Nov 26, 2022
COVID-19, Vaccines Trial in Los Angeles (Reminder to boost protection against COVID-19, Flu Tag Along, COVID-19 Booster & Flu
Recruiting
- COVID-19
- Vaccines
- Reminder to boost protection against COVID-19
- +2 more
-
Los Angeles, CaliforniaUCLA Health Department of Medicine, Quality Office
Nov 4, 2022
Immunization; Infection, Pregnancy Related, COVID-19 Trial in United States (VAX-MOM COVID-19 Intervention, Standard of Care)
Enrolling by invitation
- Immunization; Infection
- +2 more
- VAX-MOM COVID-19 Intervention
- Standard of Care
-
Los Angeles, California
- +25 more
Nov 8, 2022
COVID-19, Vaccines Trial in Los Angeles (Reminder that facilitates action, Consistency framing, Information provision about the
Recruiting
- COVID-19
- Vaccines
- Reminder that facilitates action
- +4 more
-
Los Angeles, CaliforniaUCLA Health Department of Medicine, Quality Office
Nov 8, 2022
COVID-19, Vaccines Trial in Los Angeles (Eligibility reminder, Link to a narrow set of vaccine venues, Link to a broad set of
Recruiting
- COVID-19
- Vaccines
- Eligibility reminder
- +3 more
-
Los Angeles, CaliforniaUCLA Health Department of Medicine, Quality Office
Nov 8, 2022
COVID-19 Trial in Los Angeles, Santa Monica (Colchicine Tablets, Current care per UCLA treating physicians)
Completed
- COVID-19
- Colchicine Tablets
- Current care per UCLA treating physicians
-
Los Angeles, California
- +2 more
Nov 1, 2022
Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])
Completed
- Infection Viral
- +2 more
- Enoxaparin Prefilled Syringe [Lovenox]
-
Birmingham, Alabama
- +15 more
Sep 15, 2022
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
SARS-CoV-2 Infection, COVID-19, Maternal Immunization Trial in Worldwide (BNT162b2, Placebo)
Completed
- SARS-CoV-2 Infection
- +2 more
- BNT162b2
- Placebo
-
Birmingham, Alabama
- +85 more
Aug 22, 2022
Respiratory Viral Infection, Antiviral Treatment, COVID-19 Trial in Los Angeles (Mitoquinone/mitoquinol mesylate)
Recruiting
- Respiratory Viral Infection
- +2 more
- Mitoquinone/mitoquinol mesylate
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 3, 2022